Actively delaying death to increase organ donation

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e1179 (Published 17 February 2012)
Cite this as: BMJ 2012;344:e1179

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Peter Watkinson, consultant in intensive care medicine1,
  2. Stuart McKechnie, consultant in intensive care medicine 1,
  3. Dominic Wilkinson, associate professor of neonatal medicine and bioethics2,
  4. Jonathan Salmon, consultant in intensive care medicine1,
  5. Duncan Young, consultant in intensive care medicine1
  1. 1Adult Intensive Care Unit, John Radcliffe Hospital, Oxford OX3 9DU, UK
  2. 2Women and Children’s Hospital, North Adelaide 5006, Australia
  1. peter.watkinson{at}nda.ox.ac.uk

New NICE guidance supports this but careful consideration should precede implementation

A wide imbalance exists between the number of solid organs available for transplantation and the number of potential recipients. In an attempt to tackle this imbalance, the National Institute for Health and Clinical Excellence (NICE) has recently issued a guideline that offers best practice advice to increase the number of cadaveric organs available for transplantation.1

Most solid organs donated in the United Kingdom come from patients whose hearts are still beating and in whom no brainstem function can be detected. However, such donation is decreasing worldwide as road safety and medical care improve. Consequently, much of the guideline focuses on ways to increase donation rates from patients judged to have untreatable and rapidly lethal conditions but who do not meet brainstem death criteria. Organs from such patients may be retrieved after certification of death when the heart stops beating. To minimise damage to solid organs, harvesting must occur as soon after cardiac death as possible. This largely limits donation after cardiac death to patients being managed on intensive care units (ICUs), where life sustaining treatment that was started with curative intent is subsequently deemed futile and a decision is made to withdraw it. Treatment withdrawal, and hence death, is usually …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL